In this context, Bernhardt et al. proposed a set of recommendations mainly focusing on adjuvant treatments for patients with high-grade gliomas to be treated with during the healthcare crisis, such as hypofractionated radiotherapy or withholding Temozolomide in unmethylated MGMT patients [31]. The gene discussed is MGMT; the disease is central nervous system cancer.